In the article, "Stock Picker Likes Sunnier Second Half", who might gain from "the little guy...going out of business"?

Get the Answer at

EF Hutton: In the article, "Stock Picker Likes Sunnier Second Half", who might gain from "the little guy...going out of business"?

Get All the CNBC Bonus Bucks Answers Everyday at EF Hutton

Power Lunch: In Fast Money's blog post "Second Half Options" what "trend" does Pete Najarian suggest following?

Power Lunch

In Fast Money's blog post "Second Half Options" what "trend" does Pete Najarian suggest following?
Answer: oil leading the market

Get Notification of CNBC Bonus Bucks Answers via Email

U.S. Completes Contribution to World’s Most Powerful Particle Accelerator

clipped from www.energy.gov WASHINGTON, DC - The U.S. contribution to the Large Hadron Collider (LHC) has been completed on budget and ahead of schedule, the U.S. Department of Energy (DOE) and the National Science Foundation (NSF) said today.  The LHC, located near Geneva, Switzerland at the CERN laboratory, is the largest international scientific facility ever built.  The U.S. contribution, a $531 million investment, consists of several key components of the particle accelerator and the ATLAS and CMS particle detectors.

A Look at High-Performing Franchises

clipped from online.wsj.com The fast-food industry's power-grip on the franchising industry is slowly loosening, as industries serving the consumer and residential markets are expanding rapidly and performing well financially, according to The Wall Street Journal list of 25 franchise high performers.

Lack of 'Good' HDL Cholesterol Linked to Memory Loss

If you are predisposed to Alzheimer's by birth you might want to take a close look at this article and vdieo.

My mother falls into this category so it does concern me.

clipped from health.usnews.com News today that low levels of the "good" HDL cholesterol raises a person's risk of memory loss and memory loss and dementia may send many folks rushing to their doctor for a cholesterol check. Indeed, the findings are pretty scary. Study participants with the lowest HDL levels—defined as less than 40 mg/dL—were 53 percent more likely to perform poorly on short-term memory tests compared to those with high HDL, defined as 60 mg/dL or greater. (These healthy participants were age 61, on average, experiencing the earliest signs of dementia that typically start in middle age.) Those whose HDL levels plunged over the six-year study also experienced a decrease in the number of words they were able to recall on the memory test, says study leader Archana Singh-Manoux, senior research fellow in epidemiology at the University College London. Video: Cholesterol: The Good and the Bad

Flurizan’s Failure Leaves Key Alzheimer’s Theory Unresolved

clipped from blogs.wsj.com Though Myriad Genetics was hoping its experimental Alzheimer’s drug Flurizan would surprise naysayers in the scientific and investment communities, the company instead announced that its Phase III clinical trial did indeed fail. The company said Monday that the 18-month, 1,684-patient study – the largest Alzheimer’s-treatment study to date – showed Flurizan failed to improve cognitive functioning or activities of daily living, and added that Myriad is abandoning further efforts to develop the drug. This leaves Elan and Wyeth’s bapineuzumab and Eli Lilly’s gamma secretase inhibitor as the two leading candidates among disease-modifying Alzheimer’s drugs in development.

EF Hutton: In Monday's Stock Blog post "Four Stocks to Watch This Week," which of the companies discussed posts earnings today?

EF Hutton: In Monday's Stock Blog post "Four Stocks to Watch This Week," which of the companies discussed posts earnings today?

Squawk Box

In Monday's Stock Blog post "Four Stocks to Watch This Week," which of the companies discussed posts earnings today? Answer: Constellation Brands

Get All the CNBC Bonus Bucks Answers Everyday at EF Hutton